Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
The graduating cohort comprised seven batches across five specialized programs
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery
Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Subscribe To Our Newsletter & Stay Updated
